Loading clinical trials...

Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft | Clinical Trials | Clareo Health

COMPLETED

Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

NCT02692664•JOTEC GmbH

View on ClinicalTrials.gov

Summary

In this study, patients will be observed who receive an E-liac Stent Graft for treatment of isolated iliac aneurysms or an E-liac Stent Graft in combination with one of the following AAA stent grafts: E-tegra Stent Graft, Endurant AAA Stent Graft, Zenith AAA Endovascular Graft, Gore Excluder AAA Endoprosthesis for treatment of aorto-iliac aneurysms. Objectives of this post-market registry are: Primary: To prevent the risk of rupture and death by the treatment of common iliac aneurysm with an iliac branched stent graft (E-liac, JOTEC) Secondary: Evaluation of safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aorto-iliac or iliac aneurysm.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Unilateral or bilateral aorto-iliac or iliac aneurysm
•Suitable for endovascular repair
•Patient must be compliant with life- long follow-up investigations
•\>18 years old
•lliac/femoral access vessel morphology compatible with the implantation procedure and the 18Fr (6mm OD) delivery system
•Non-aneurysmal common iliac artery landing area in case of iliac artery aneurysm ≥ 20mm
•Diameter of the common iliac artery in the proximal landing area: 12mm to 17mm
•Non-aneurysmal external iliac artery segment distal to the aneurysm ≥15mm
•Diameter of the external iliac artery in the distal landing area: 8mm to 13mm
•Non-aneurysmal internal iliac artery segment distal to the aneurysm ≥15mm
+10 more criteria

Exclusion Criteria

•Patients who do not meet the instructions for use
•Patients with one of the contraindications as indicated in the instructions for use
•Patients with a stenotic internal iliac ostium of \< 4mm in Diameter
•Patients with severe internal iliac atherosclerosis
•Patients that do not have a suitable landing area in the main stem of the IIA (maximum diameter in landing area \<12mm)
•Patients with pseudoaneurysms
•Patients with symptomatic and ruptured iliac aneurysms
•Patients pretreated with a AAA stent graft or a bifurcated vascular graft
•Patient with thrombocytopenia
•Patient with an estimated glomerular filtration rate \< 30 ml/min/1,73m2 immediately before the Intervention
+6 more criteria

Locations (2)

CHU Nantes

Nantes, France

CHU Rennes

Rennes, France

Key Dates

Start Date

May 1, 2016

Primary Completion Date

July 5, 2024

Completion Date

July 5, 2024

Last Updated

February 17, 2026

Enrollment

ACTUAL participants

Conditions

Iliac AneurysmAAA

Interventions

Endovascular aorto-iliac repair

DEVICE

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

NCT06218875

AAA - Abdominal Aortic Aneurysm

View study

RECRUITING

Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery

NCT06884397

Abdominal Aortic Aneurysms (AAA)

View study

RECRUITINGNA

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

NCT05064540

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

Inclusion Criteria

Exclusion Criteria

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Use of Artificial Intelligence to Predict Complications Following Abdominal Aortic Surgery

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall

Post-operative Quality of Life After AAA Management: EVAR Versus Open Repair

Prediction of Abdominal Aortic Aneurysm Shrinkage After Stent-placement With Artificial Intelligence